Inderbir Gill, M.D., M.Ch.

Inderbir Singh Gill, MD, is Head of the Section of Laparoscopic and Minimally Invasive Surgery in the Urological Institute at Cleveland Clinic in Cleveland, Ohio. His clinical interests are laparoscopic and minimally invasive surgery of the adrenal gland, kidney, prostate and bladder; renal transplantation; and renovascular surgery.

Dr. Gill has been listed in Best Doctors in America and as one of the best doctors in Cleveland by Cleveland magazine. He is a recipient of the Pfizer Scholars in Urology Award from the University of Nebraska Medical Center.
 
Board-certified in surgery and urology, Dr. Gill is active in scientific publication, having published more than 150 scientific papers and two textbooks. He is a Section Editor for Urology and Techniques in Urology. In addition, he is a reviewer for a number of peer-reviewed publications including Journal of Urology, Journal of Endourology, and Urology. He has been an invited speaker/visiting professor to approximately 80 institutions. Under his leadership, the Section of Laparoscopic and Minimally Invasive Surgery in the Urological Institute is one of the premier groups in the world.

He earned his medical degree from Government Medical College Punjabi University in Patiala, India, where he also completed his internship. He completed a residency in general surgery at Dayanand Medical College and Hospital in Ludihana, India, and a residency in urology at All India Institute of Medical Sciences in New Delhi, India. In addition, Dr. Gill completed a residency in urology at the University of Kentucky Medical Center in Lexington. He also completed a fellowship in renal transplantation and renovascular surgery at Cleveland Clinic.

Laparoscopic and minimally invasive surgery of the adrenal gland, kidney, prostate and bladder, renal transplantation, renovascular surgery.

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 10/24/2008 the review process regarding Dr. Gill’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)